# Expanded Access for ACE-011

> **NCT03724227** · — · NO_LONGER_AVAILABLE · sponsor: **Celgene**

## Conditions studied

- Myelodysplastic Syndrome

## Interventions

- **DRUG:** ACE-011

## Key facts

- **NCT ID:** NCT03724227
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2020-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03724227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03724227, "Expanded Access for ACE-011". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03724227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*